Le Lézard
Classified in: Science and technology
Subject: Award

The Boston Globe Names ChaosSearch a Top Place to Work for 2021

ChaosSearch announced today that it has been named one of the Top Places to Work in Massachusetts in the 14th annual employee-based survey project from The Boston Globe. This recognition follows the company's placement on The Boston Business Journal's 2021 Best Places to Work list, solidifying its commitment to creating exceptional work environments that foster employee happiness and growth.

The Boston Globe's annual Top Places to Work recognizes the most admired workplaces in the state as voted on by the people who know them best: their employees. The rankings are based on confidential survey information collected by Energage (formerly WorkplaceDynamics), an independent company specializing in employee engagement and retention. The survey measures employee opinions about everything from workplace flexibility and leadership to company values and compensation. More than 80,000 individuals spanning across 363 Massachusetts organizations participated in this year's nomination and evaluation process, and 150 employers were ultimately recognized. ChaosSearch ranked 5th overall in the small company category.

"At ChaosSearch, we are dedicated to providing constant support and resources to cultivate our greatest asset: our people," said Ed Walsh, CEO, ChaosSearch. "The past year has proven how important that commitment is?particularly as we continue to scale our business amidst a pandemic. It requires a lot of creativity and flexibility to foster a collaborative environment with an energizing culture. The hard work and dedication of our employees has made this a momentous year, and we're incredibly proud to be recognized as a workplace that supports their professional development."

ChaosSearch is hiring across the organization and has tripled the size of its team over the last year. For more information, visit www.chaossearch.io/careers.

About ChaosSearch
ChaosSearch helps modern organizations Know Bettertm by activating the data lake for analytics. The ChaosSearch Data Lake Platform indexes customers' cloud data, rendering it fully searchable and enabling analytics at scale with massive reductions of time, cost and complexity.

ChaosSearch was purpose-built for cost-effective, highly scalable analytics encompassing full text search, SQL and machine learning capabilities in one unified offering. The patented ChaosSearch technology instantly transforms your cloud object storage (Amazon S3, Google Cloud Storage) into a hot, analytical data lake.

The Boston-based company raised $40M Series B in December 2020 and is hiring to support its hyper growth. For more information, visit ChaosSearch.io or follow us on Twitter @ChaosSearch and LinkedIn.

These press releases may also interest you

at 01:50
InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) accepted a...

at 01:15
The IVAR Coin (IVAR) is now listed on XT.com as an IVAR and Tether (USDT) trading pair. For all traders, the most promising crypto trading experience of IVAR/USDT is available on the exchange's Main Zone (Metaverse). Participants who haven't traded...

at 00:24
Daqo New Energy Corp. ("Daqo New Energy," the "Company" or "we"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced that it has published its 2021 Environmental, Social and Governance (ESG) report. ...

11 aoû 2022
EDCON, a non-profit annual global Ethereum conference and De University of Ethereum (UETH), a decentralized global educational platform initiated by the Ethereum community announced today that its interactive symposium, "Ethereum a New Era", will...

11 aoû 2022
Allied Market Research recently published a report, titled, "Satellite Connectivity Market by Component (Video, Fixed, Mobility), by Orbit (Elliptical, GEO, LEO, MEO), by End User (Civil and Earth Observation, Government and Military, Commercial):...

11 aoû 2022
Daiichi Sankyo (TSE: 4568) and AstraZeneca's (LSE/STO/Nasdaq: AZN) ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic non-small cell lung cancer (NSCLC) whose...

News published on 22 december 2021 at 09:05 and distributed by: